Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ContraVir to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention | ||||||||||||||
By: PR Newswire Association LLC. - 24 Oct 2016 | Back to overview list |
|||||||||||||
EDISON, N.J., Oct. 24, 2016 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced that it will present at Sidoti & Company Fall 2016 Emerging Growth Convention, to be held November 1, 2016, in New York City. Senior Vice President of Drug Development, Theresa Matkovits, Ph.D., will provide an overview of the company's business during a live presentation, and will be available to participate in one-on-one meetings with investors who are registered to attend the conference. Investors interested in attending and scheduling a one-on-one meeting should click here: Conference Details
About ContraVir Pharmaceuticals For further information, please contact: Sharen Pyatetskaya Tiberend Strategic Advisors, Inc. Claire LaCagnina (media)
SOURCE ContraVir Pharmaceuticals, Inc. |
||||||||||||||
|
||||||||||||||
Copyright 2016 PR Newswire Association LLC. | Back to overview list |